Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Nivolumab blocking PD1 in lung cancer and melanoma

Crizotinib and molecular testing in advanced non small cell lung cancer

Nintedanib in combination with standard second line therapy in lung cancer

The problem of unnecessary treatment of prostate cancer

Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer

One in five african american women with breast cancer carry inherited mutations

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery

Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer

Surveys reveal shortages of common cancer drugs are ongoing

Selumetinib, the first effective drug for advanced melanoma of the eye